Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Gum or Inhaler for Smoking Reduction or Cessation
NCT00840242Phase 3Completed
- Sponsor
- McNeil Laboratories
- Start
- Feb 1999
- Primary completion
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by McNeil Laboratories. Started Feb 1999; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00840242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840242.